Ophthalmologic Safety of Long Term Treatment With Pramipexole Compared to Bromocriptine or Other Dopamine Agonists in Patients With Parkinson's Disease

• Status: Completed
• Trial end date: 1969-12-31

Summary

Study to assess and compare the safety of long term oral treatment for Parkinson's Disease with pramipexole versus bromocriptine or other dopamine agonists, by measuring cross-sectional the incidence of ophthalmologic disturbances, especially signs of retinal degeneration, in a matched pair design

• Phase: Phase 4

Details

• Lead Sponsor: Boehringer Ingelheim
• Treatments: Bromocriptine; Dopamine; Dopamine Agents; Dopamine Agonists; Pramipexole